Asiaticon, SA de CV

Warning LetterOpen

MexicoIssued Oct 29, 2020

Letter not published by FDA

Source: FDA warning letter records. FDA has not published the text of this letter.

Violations0

Issue DateOct 29, 2020

Product TypeDrugs

StatusOpen

Letter Details

Firm: Asiaticon, SA de CV
Location: Mexico
FEI Number: N/A
Country: Mexico
Issue Date: October 29, 2020
Issuing Office: N/A
Product Type: Drugs
Status: Open

Summary

Based on limited metadata, this FDA Warning Letter issued to Asiaticon, SA de CV on October 29, 2020, concerns drug manufacturing or marketing practices. Without access to the full letter text or specific subject line details, the exact nature of the violations cannot be determined, though the warning indicates the company failed to meet FDA regulatory requirements for drug products. The enforcement action falls under FDA's drug regulation authority, though the specific issuing office and violation count are not specified in the available metadata.

Asiaticon, SA de CV FDA Warning Letter, October 29, 2020